Skip to content

PTGX

Protagonist Therapeutics, Inc.

Stock

$140.06+0.87 (+0.63%)Close Oct 2, 2026

Adjusted price

+115.54% total return, past year

Key statistics

Market cap
$9.1B
P/E (TTM)
136.4
52-week range
$64.14$158.62
Beta (5Y monthly)
1.52
Median dollar volume
$87.1M
Shares outstanding
64.7M
Revenue, last 12 months
$282M
Sector
Health Care
First close
Aug 11, 2016

Total

1M
−4.1%
YTD
+60.4%
1Y
+115.5%

Per year

3Y
+104.7%
5Y
+50.8%
10Y
+20.8%
Since 2016
+27.7%

Financials

Revenue

$282MLast 12 months

Operating income

$58MLast 12 months

Net income

$83MLast 12 months

EPS

$1.03Last 12 months

Free cash flow

$131MLast 12 months

Annual returns

2016 from Aug 11 · 2026 through Oct 2